{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:02:52Z","timestamp":1793250172372,"version":"4.5.0"},"reference-count":215,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":3683,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1600-6143.2012.04223.x","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T13:25:02Z","timestamp":1345209902000},"page":"2875-2891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Future of Heart Transplantation"],"prefix":"10.1016","volume":"12","author":[{"given":"J.A.","family":"Kobashigawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2012.04223.x_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report\u20142011","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib2","series-title":"OPTN \/ SRTR 2010 Annual Data Report.","first-page":"89","year":"2011"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCHEARTFAILURE.111.964247","article-title":"Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts","volume":"5","author":"Singh","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib4","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.healun.2005.03.015","article-title":"Multi-organ transplantation: Is there a protective effect against acute and chronic rejection?","volume":"24","author":"Pinderski","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00007890-200301150-00008","article-title":"Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities","volume":"75","author":"Pei","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib6","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.athoracsur.2011.07.082","article-title":"Impact of virtual cross match on waiting times for heart transplantation","volume":"92","author":"Yanagida","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/TP.0b013e318191404c","article-title":"A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation","volume":"86","author":"Bingaman","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib9","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD41CD251regulatory T cells.","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.4049\/jimmunol.168.3.1080","article-title":"CD25+CD4+Regulatory T cells prevent graft rejection: CTLA-4- and IL-10- dependent immunoregulation of alloresponses","volume":"168","author":"Kingsley","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib13","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/eji.1830250936","article-title":"Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response","volume":"25","author":"Bushell","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00007890-199609270-00026","article-title":"Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for the maintenance of tolerance to alloantigen in anti-CD4 treated recipients","volume":"62","author":"Hamano","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib15","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/TP.0b013e3181777a39","article-title":"The B-cell response to protein antigens in immunity and transplantation","volume":"85","author":"Tarlinton","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib17","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib18","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a crossplatform biomarker signature to detect renal transplant tolerance in humans","volume":"120","author":"Sagoo","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-6143.2010.03336.x","article-title":"Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile","volume":"11","author":"Le Texier","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrrheum.2010.140","article-title":"Regulatory B cells in autoimmunity: Developments and controversies","volume":"6","author":"Mauri","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib21","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","article-title":"Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells","volume":"186","author":"Carter","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib23","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e3181efcfe9","article-title":"The significance of non-T-cell pathways in graft rejection: Implications for transplant tolerance","volume":"90","author":"Li","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0b013e318186ac4a","article-title":"Impact of innate and adaptive immunity on rejection and tolerance","volume":"86","author":"Kim","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/TP.0b013e3181b22cec","article-title":"Endoplasmic reticulum stress: An unrecognized actor in solid organ transplantation","volume":"88","author":"Pallet","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib26","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1600-6143.2007.01980.x","article-title":"Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants","volume":"7","author":"Famulski","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2741\/2672","article-title":"Organ reperfusion and preservation","volume":"13","author":"Jamieson","year":"2008","journal-title":"Front Biosci"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib28","unstructured":"TransMedics. Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation (PROCEEDII). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00855712. Accessed 2011."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","article-title":"Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses","volume":"6","author":"Fudaba","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib30","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1432-2277.2008.00783.x","article-title":"Clinical experience with mixed chimerism to induce transplantation tolerance","volume":"21","author":"Fehr","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib31","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib32","unstructured":"National Institute of Health. Bone marrow transplant to induce tolerance in heart transplant recipients. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00497757. Accessed 2011."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/TP.0b013e31819f2024","article-title":"ABO incompatible renal transplantation: A paradigm ready for broad implementation","volume":"87","author":"Montgomery","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-6143.2007.02040.x","article-title":"Multicenter experience of ABO-incompatible pediatric cardiac transplantation","volume":"8","author":"Roche","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib35","doi-asserted-by":"crossref","first-page":"970421","DOI":"10.1155\/2011\/970421","article-title":"ABO incompatible kidney transplantation-current status and uncertainties","volume":"2011","author":"Shin","year":"2011","journal-title":"J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1510\/icvts.2009.229757","article-title":"Does ABO-incompatible and ABO-compatible neonatal heart transplant have equivalent survival?","volume":"10","author":"Saczkowski","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1399-3089.2006.00324.x","article-title":"ABO-incompatible allotransplantation as a basis for clinical xenotransplantation","volume":"13","author":"Stussi","year":"2006","journal-title":"Xenotransplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib38","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib41","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from post-transplant lymphoproliferative disorder at allograft protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4020-5133-3_24","article-title":"Targeting mTOR for cancer treatment","volume":"587","author":"Rubio-Viqueira","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib44","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib45","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.transproceed.2004.05.074","article-title":"Pharmacokinetics of sirolimus in heart transplant recipients with chronic renal impairment","volume":"36","author":"Moloney","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib47","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib48","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/TP.0b013e3181a27683","article-title":"Reconstitution of peripheral allospecific CD19 + B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients","volume":"87","author":"Kopchaliiska","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib49","unstructured":"National Institute of Allergy and Infectious Diseases. Prevention of cardiac allograft vasculopathy using rituximab (rituxan) therapy in cardiac transplantation. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01278745. Accessed 2011."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00063030-200620020-00003","article-title":"Efficacy of alemtuzumab in organ transplantation: current clinical status","volume":"20","author":"Ciancio","year":"2006","journal-title":"BioDrugs"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-6143.2009.02856.x","article-title":"Alemtuzumab induction prior to cardiac transplantation with lower intensity maintenance immunosuppression: one-year outcomes","volume":"10","author":"Teuteberg","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib53","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteosome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mot.0000186082.47623.76","article-title":"Enhanced immunosuppression induced by targeted mutation of cytotoxic T lymphocyte antigen-4 immunoglobulin","volume":"10","author":"Kokko","year":"2005","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1600-6143.2005.00749.x","article-title":"Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-lg with potent immunosuppressive properties","volume":"5","author":"Larsen","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib56","unstructured":"Bristol-Myers Squibb. Indication and important safety information, Nulojix (belatacept). Available at: http:\/\/www.nulojix.com\/hcp\/index.aspx. Accessed February 2012."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1600-6143.2006.01259.x","article-title":"A new look at T cell costimulation: A therapeutic strategy for long-term maintenance immunosuppression","volume":"6","author":"Larsen","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Co-stimulation blockade with belatacept in renal transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib59","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/TP.0b013e3182007b95","article-title":"An integrated safety profile analysis of belatacept in kidney transplant recipients","volume":"90","author":"Griny\u00f3","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib61","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib63","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","article-title":"Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome","volume":"9","author":"Chatelet","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/TP.0b013e3181ccd80d","article-title":"Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation","volume":"89","author":"Larrea","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib65","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/ndt\/gfp775","article-title":"Effects of the new immunosuppressive agent AEB071 on human immune cells","volume":"25","author":"Matz","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 118","key":"10.1111\/j.1600-6143.2012.04223.x_bib66","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/ki.2010.211","article-title":"Potential of emerging immunosuppressive strategies to improve the posttransplant cardiovascular risk profile","volume":"78","author":"Djamali","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib67","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ddr.20487","article-title":"Beyond transitional selection: New roles for BLyS in peripheral tolerance","volume":"72","author":"Oropallo","year":"2011","journal-title":"Drug Dev Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.ftd.0000183385.27394.e7","article-title":"Active drug transport of immunosuppressants: New insights for pharmacokinetics and pharmacodynamics","volume":"28","author":"Christians","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib69","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/TP.0b013e318200e991","article-title":"Novel polymorphisms associated with tacrolimus trough concentrations: Results from a multicenter kidney transplant consortium","volume":"91","author":"Jacobson","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib71","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.transproceed.2010.05.129","article-title":"Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantation","volume":"42","author":"Herrero","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.healun.2009.11.602","article-title":"Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients","volume":"9","author":"Ohmann","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib73","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/CIRCULATIONAHA.109.913921","article-title":"Identification and classification of acute cardiac rejection by intragraft transcriptional profiling","volume":"123","author":"Holweg","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib74","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMoa0801861","article-title":"C3 polymorphisms and allograft outcome in renal transplantation","volume":"360","author":"Varagunam","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/TP.0b013e3182105fb8","article-title":"Transplantomics and biomarkers in organ transplantation: A report from the first international conference","volume":"91","author":"Sarwal","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nmeth.1439","article-title":"Cell type-specific gene expression differences in complex tissues","volume":"7","author":"Shen-Orr","year":"2010","journal-title":"Nat Methods"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib77","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.coi.2010.08.009","article-title":"Non-MHC antigenic targets of the humoral immune response in transplantation","volume":"22","author":"Zhang","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib78","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1158\/0008-5472.CAN-10-1843","article-title":"Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects","volume":"70","author":"Patel","year":"2010","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib79","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1073\/pnas.0705834104","article-title":"Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance","volume":"104","author":"Brouard","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib80","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.transproceed.2009.06.136","article-title":"Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients","volume":"41","author":"Perez-Flores","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.healun.2008.10.001","article-title":"Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients","volume":"28","author":"Rossano","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib82","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib83","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2007.09.017","article-title":"Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients","volume":"26","author":"Bernstein","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib84","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/gm253","article-title":"Biomarkers in solid organ transplantation: Establishing personalized transplantation medicine","volume":"3","author":"Roedder","year":"2011","journal-title":"Genome Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib87","first-page":"559","article-title":"Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in man","volume":"24","author":"Good","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib88","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1068228","article-title":"Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning","volume":"295","author":"Lai","year":"2002","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.1078942","article-title":"Production of \u03b1 1,3-galactosyltransferase-deficient pigs","volume":"299","author":"Phelps","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib90","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1097\/00007890-200006270-00008","article-title":"Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons","volume":"69","author":"Cowan","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3089.2010.00569.x","article-title":"Complement regulation in the GalT KO era","volume":"17","author":"Miyagawa","year":"2010","journal-title":"Xenotransplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib92","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jtcvs.2005.04.017","article-title":"Cardiac xenotransplantation: Recent preclinical progress with 3-month median survival","volume":"130","author":"McGregor","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib93","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1600-6143.2009.02602.x","article-title":"Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation","volume":"9","author":"Knosalla","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib94","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(11)61091-X","article-title":"Clinical xenotransplantation: The next medical revolution?","volume":"379","author":"Ekser","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-3089.2008.00476.x","article-title":"Recombinant pig TFPI effi ciently regulates human tissue factor pathways","volume":"15","author":"Lee","year":"2008","journal-title":"Xenotransplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib96","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1600-6143.2008.02210.x","article-title":"Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI","volume":"8","author":"Roussel","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib97","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/j.1600-6143.2010.03257.x","article-title":"Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury","volume":"10","author":"Crikis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib98","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1096\/fj.08-119701","article-title":"Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN traffi cking into the lungs","volume":"23","author":"Reutershan","year":"2009","journal-title":"FASEB J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib99","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1034\/j.1600-6143.2002.20405.x","article-title":"Activation of natural killer cells and macrophages by porcine endothelial cells augments specifi c T-cell xenoresponse","volume":"2","author":"Xu","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib100","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.180.9.6346","article-title":"Cytokine secretion depends on Gal\u03b1(1,3)Gal expression in a pig-to-human whole blood model","volume":"180","author":"Saethre","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib101","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib102","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib103","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib104","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib106","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(97)00104-6","article-title":"Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials","volume":"30","author":"Heidenreich","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib107","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-134-7-200104030-00008","article-title":"Beta-blockers in congestive heart failure: A Bayesian meta-analysis","volume":"134","author":"Brophy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib108","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib109","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/eurheartj\/ehn543","article-title":"Aldosterone blockade and left ventricular dysfunction: A systematic review of randomized clinical trials","volume":"30","author":"Ezekowitz","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib111","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib112","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib113","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib114","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/jama.297.22.2502","article-title":"Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review","volume":"297","author":"McAlister","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib115","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/eurheartj\/ehl203","article-title":"Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials","volume":"27","author":"Rivero-Ayerza","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib116","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib118","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib119","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ahj.2011.01.027","article-title":"Potential impact of optimal implementation of evidence-based heart failure therapies on mortality","volume":"161","author":"Fonarow","year":"2011","journal-title":"Am Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib121","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/14779072.5.3.585","article-title":"Reversing chronic remodeling in heart failure","volume":"5","author":"Mudd","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib122","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","article-title":"Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction","volume":"111","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCHEARTFAILURE.109.906909","article-title":"Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction","volume":"3","author":"Udelson","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib124","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.167.10.989","article-title":"Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis","volume":"167","author":"Abdel-Latif","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib125","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib126","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2004.07.017","article-title":"Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation","volume":"44","author":"Athanasuleas","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","article-title":"Reverse remodeling in heart failure\u2013mechanisms and therapeutic opportunities","volume":"9","author":"Koitabashi","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: Potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib129","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: Insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib130","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib131","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): The association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib132","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: Results of a 1 year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib133","unstructured":"National Heart, Lung, and Blood Institute (NHLBI). Evaluating the effectiveness of sildenafil at improving health outcomes and exercise ability in people with diastolic heart failure (The RELAX Study). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00763867. Accessed 2011."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapyin cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J Card Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib136","doi-asserted-by":"crossref","first-page":"92ra64","DOI":"10.1126\/scitranslmed.3002097","article-title":"Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model","volume":"3","author":"Pleger","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib137","unstructured":"US National Library of Medicine. A study of the safety and efficacy of injectable thymosin beta 4 for treating acute myocardial infarction. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01311518. Accessed 2011."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib138","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","article-title":"CaMKII in myocardial hypertrophy and heart failure","volume":"51","author":"Anderson","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib139","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.pharmtox.48.121806.154902","article-title":"PKC isozymes in chronic cardiac disease: possible therapeutic targets?","volume":"48","author":"Churchill","year":"2008","journal-title":"Annu. Rev. Pharmacol Toxicol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12265-010-9208-4","article-title":"TRP-ing up heart and vessels: Canonical transient receptor potential channels and cardiovascular disease","volume":"3","author":"Rowell","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib141","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","article-title":"Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart","volume":"89","author":"Creemers","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib142","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ahj.2008.11.006","article-title":"Effects of cardiac resynchronization therapy on long-term quality of life: An analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study","volume":"157","author":"Cleland","year":"2009","journal-title":"Am Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib143","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1751-7133.2011.00227.x","article-title":"Cellular evidence of reverse cardiac remodeling induced by cardiac resynchronization therapy","volume":"17","author":"Orrego","year":"2011","journal-title":"Congest Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib144","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiacresynchronization therapy for the prevention of heart-failure events","volume":"2009","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib145","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib146","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.05.009","article-title":"Clinical and genetic modifiers of long-term survival in heart failure","volume":"54","author":"Cresci","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib147","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCHEARTFAILURE.109.866822","article-title":"Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: Results from the Genetic Risk Assessment in Heart Failure substudy","volume":"2","author":"Rame","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib148","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI39085","article-title":"Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease","volume":"120","author":"Matkovich","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib149","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0140-6736(93)92061-W","article-title":"Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy","volume":"342","author":"Raynolds","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.109.895763","article-title":"The association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: A prospective meta-analysis from the CHARGE consortium","volume":"3","author":"Smith","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib151","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIRCGENETICS.109.895995","article-title":"Genomic variation associated with mortality among adults of European and African ancestry with heart failure: The CHARGE consortium","volume":"3","author":"Morrison","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib152","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.yjmcc.2006.08.009","article-title":"Differential gene expression profiling in genetic and multifactorial cardiovascular diseases","volume":"41","author":"Nanni","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib153","doi-asserted-by":"crossref","first-page":"145901467","DOI":"10.1161\/CIRCRESAHA.110.217513","article-title":"Deep mRNA sequencing for invivo functional analysis of cardiac transcriptional regulators: Application to Galphaq","volume":"106","author":"Matkovich","year":"2010","journal-title":"Circulation Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib154","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molcel.2006.05.026","article-title":"Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR","volume":"23","author":"Creemers","year":"2006","journal-title":"Mol Cell"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11886-010-0096-7","article-title":"Therapeutic potential of microRNAs in heart failure","volume":"12","author":"Dorn","year":"2010","journal-title":"Curr Cardiol Rep"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib156","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"van Rooij","year":"2009","journal-title":"Dev Cell"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib157","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.CIR.0000129233.51320.92","article-title":"Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy","volume":"109","author":"Terracciano","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib158","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","article-title":"Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure","volume":"51","author":"Kawase","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib159","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib160","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"issue":"4 Suppl","key":"10.1111\/j.1600-6143.2012.04223.x_bib161","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced heart failure","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib162","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.healun.2008.12.015","article-title":"Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?","volume":"28","author":"Levy","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib163","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.107.691972","article-title":"Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection","volume":"116","author":"Lietz","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib164","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.02.032","article-title":"Risk assessment for continuous flow left ventricular assist devices: Does the destination therapy risk score work?","volume":"60","author":"Teuteberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib165","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.jacc.2008.03.009","article-title":"The right ventricular failure risk score","volume":"51","author":"Matthews","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib166","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.healun.2008.09.006","article-title":"Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support","volume":"27","author":"Fitzpatrick","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib167","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","article-title":"INTERMACS profiles of advanced heart failure: The current picture","volume":"28","author":"Stevenson","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib168","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2012.02.031","article-title":"Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time","volume":"60","author":"Dardas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib169","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jtcvs.2010.03.046","article-title":"Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support","volume":"141","author":"John","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib170","first-page":"E23","article-title":"Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction","volume":"22","author":"Kiernan","year":"2010","journal-title":"J Invasive Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib171","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14017430802715954","article-title":"Experience with the Impella recovery axial-flow system for acute heart failure at three cardiothoracic centers in Sweden","volume":"43","author":"Granfeldt","year":"2009","journal-title":"Scand Cardiovasc J"},{"issue":"Suppl 2","key":"10.1111\/j.1600-6143.2012.04223.x_bib172","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1055\/s-0029-1240687","article-title":"Partial mechanical long-term support with the CircuLite Synergy pump as bridge-to-transplant in congestive heart failure","volume":"58","author":"Klotz","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib173","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib174","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: A meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.healun.2010.05.016","article-title":"Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial","volume":"29","author":"Wieselthaler","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib176","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccl.2011.08.002","article-title":"Toward total implantability using free-range resonant electrical energy delivery system: Achieving untethered ventricular assist device operation over large distances","volume":"29","author":"Waters","year":"2011","journal-title":"Cardiol Clin"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib177","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/eurheartj\/ehl365","article-title":"Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy","volume":"28","author":"Hall","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib178","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jacc.2010.11.010","article-title":"Clinical, molecular, and genomic changes in response to a left ventricular assist device","volume":"57","author":"Hall","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib179","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/CIRCULATIONAHA.108.813576","article-title":"Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support","volume":"119","author":"Matkovich","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib180","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.109.933960","article-title":"Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacologic therapy: A prospective study","volume":"123","author":"Birks","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib181","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10741-012-9300-8","article-title":"The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: Implications for heart failure in the elderly","volume":"17","author":"Butler","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib182","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-5876-9-12","article-title":"Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion","volume":"9","author":"Anastasiadis","year":"2011","journal-title":"J Transl Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib183","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa040186","article-title":"Cardiac replacement with a total artificial heart as a bridge to transplantation","volume":"351","author":"Copeland","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib184","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jtcvs.2011.12.002","article-title":"Experience with more than 100 total artificial heart implants","volume":"143","author":"Copeland","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib185","unstructured":"SynCardia Systems. Inc. SynCardia Freedom Driver System Study. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00733447. Accessed 2010."},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib186","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1525-1594.2011.01321.x","article-title":"One-month biocompatibility evaluation of the pediatric TinyPump in goats","volume":"35","author":"Ando","year":"2011","journal-title":"Artif Organs"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib187","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1073\/pnas.2132126100","article-title":"Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib188","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib189","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2004.08.014","article-title":"Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: Final one-year results of the TOPCARE-AMI Trial","volume":"44","author":"Sch\u00e4chinger","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib190","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomized phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib191","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2007.07.041","article-title":"Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials","volume":"50","author":"Lipinski","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib192","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib193","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","article-title":"Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.","volume":"94","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib194","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/eurjhf\/hfp113","volume":"11","author":"Sch\u00e4chinger","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib195","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months\u2019 follow-up data from the randomized, controlled BOOST (Bone marrOw transfer to enhance ST-elevation infarct regeneration) Trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib196","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1073\/pnas.0610024104","article-title":"Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair","volume":"104","author":"Mirotsou","year":"2007","journal-title":"Proc Natl Acad. Sci USA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib197","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasche","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib198","first-page":"58","article-title":"C-kit-positive cardiac stem cells and myocardial regeneration","volume":"2","author":"Hosoda","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib199","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.108.175505","article-title":"Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents","volume":"102","author":"van Laake","year":"2008","journal-title":"Circ Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib200","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/CIRCRESAHA.109.203109","article-title":"iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism","volume":"105","author":"Martinez-Fernandez","year":"2009","journal-title":"Circ Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib201","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib202","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib203","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib204","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiospherederived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib206","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1161\/CIRCULATIONAHA.109.909291","article-title":"Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: Role of cardiovascular lineage commitment","volume":"121","author":"Yoon","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib207","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.yjmcc.2005.07.003","article-title":"Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells","volume":"39","author":"Urbich","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib208","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib209","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.RES.0000209515.59115.70","article-title":"Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo","volume":"98","author":"Furuta","year":"2006","journal-title":"Circ Res"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib210","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/01.tp.0000181163.69108.dd","article-title":"Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: Their integration with recipient myocardium","volume":"80","author":"Miyagawa","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib211","first-page":"719","article-title":"Myocardial regeneration for heart failure","volume":"68","author":"Sawa","year":"2010","journal-title":"Nippon Rinsho"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib212","doi-asserted-by":"crossref","first-page":"16568","DOI":"10.1073\/pnas.0908381106","article-title":"Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue","volume":"106","author":"Stevens","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/ten.tea.2009.0130","article-title":"Transplantation of a tissue-engineered human vascularized cardiac muscle","volume":"16","author":"Lesman","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib214","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: Using nature\u2019s platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2012.04223.x_bib215","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.copbio.2009.10.016","article-title":"From stem cells and cadaveric matrix to engineered organs","volume":"20","author":"Taylor","year":"2009","journal-title":"Curr Opin Biotechnol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2012.04223.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352227676X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352227676X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2012.04223.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:00:03Z","timestamp":1761627603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352227676X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":215,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S160061352227676X"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04223.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Future of Heart Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04223.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}